Timothy Shaw - Oct 27, 2024 Form 4 Insider Report for MARIMED INC. (MRMD)

Signature
/s/ Timothy Shaw
Stock symbol
MRMD
Transactions as of
Oct 27, 2024
Transactions value $
-$5,381
Form type
4
Date filed
10/29/2024, 05:06 PM
Previous filing
Sep 10, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRMD Common stock Options Exercise $0 +111K +1.28% $0.00 8.77M Oct 27, 2024 Direct F1
transaction MRMD Common stock Tax liability -$5.38K -32.6K -0.37% $0.17 8.73M Oct 27, 2024 Direct F2
holding MRMD Common stock 2M Oct 27, 2024 By the Shaw Family Trust F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRMD Restricted Stock Units (RSU) Options Exercise $0 -111K -33.33% $0.00 222K Oct 27, 2024 Common Stock, par value $.001 per share 111K Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 RSUs convert to shares of common stock on a one-for-one basis.
F2 Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs.
F3 The reporting person's spouse is the trustee of the trust and the shares held in the trust are for the benefit of the reporting person's children. The trust is an irrevocable trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F4 The RSUs were granted on October 27, 2022 and vested as to one-sixth on each of April 27, 2023, October 27, 2023, April 27, 2024 and October 27, 2024; the remaining one-third will vest in two equal installments thereafter, on April 27, 2025 and October 27, 2025.